BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21041870)

  • 41. More than the blues: perinatal depression.
    Isaac C; Schlife J
    Nebr Nurse; 2007; 40(3):8-13; quiz 14-5, 23. PubMed ID: 17915611
    [No Abstract]   [Full Text] [Related]  

  • 42. The relationship between oxytocin blood concentrations and antidepressants over pregnancy and the postpartum.
    Galbally M; Watson SJ; Keelan JA; Spigset O; Lewis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110218. PubMed ID: 33346016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
    Nulman I; Rovet J; Stewart DE; Wolpin J; Pace-Asciak P; Shuhaiber S; Koren G
    Am J Psychiatry; 2002 Nov; 159(11):1889-95. PubMed ID: 12411224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of depression and treatment in pregnant and postpartum women.
    Bowen A; Bowen R; Butt P; Rahman K; Muhajarine N
    Can J Psychiatry; 2012 Mar; 57(3):161-7. PubMed ID: 22398002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Depression, Anxiety, and Trauma With Cannabis Use During Pregnancy.
    Young-Wolff KC; Sarovar V; Tucker LY; Goler NC; Alexeeff SE; Ridout KK; Avalos LA
    JAMA Netw Open; 2020 Feb; 3(2):e1921333. PubMed ID: 32074285
    [No Abstract]   [Full Text] [Related]  

  • 46. Anxiety and depression symptoms in women and men from early pregnancy to 3-months postpartum: parity differences and effects.
    Figueiredo B; Conde A
    J Affect Disord; 2011 Jul; 132(1-2):146-57. PubMed ID: 21420178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exercise frequency and maternal mental health: Parallel process modelling across the perinatal period in an Australian pregnancy cohort.
    Watson SJ; Lewis AJ; Boyce P; Galbally M
    J Psychosom Res; 2018 Aug; 111():91-99. PubMed ID: 29935761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Latent trajectory groups of perinatal depressive and anxiety symptoms from pregnancy to early postpartum and their antenatal risk factors.
    Ahmed A; Feng C; Bowen A; Muhajarine N
    Arch Womens Ment Health; 2018 Dec; 21(6):689-698. PubMed ID: 29654413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal anxiety disorders prior to conception, psychopathology during pregnancy and early infants' development: a prospective-longitudinal study.
    Martini J; Wittich J; Petzoldt J; Winkel S; Einsle F; Siegert J; Höfler M; Beesdo-Baum K; Wittchen HU
    Arch Womens Ment Health; 2013 Dec; 16(6):549-60. PubMed ID: 24057868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychopharmacological treatment of mood and anxiety disorders during pregnancy.
    Krüger S
    Handb Exp Pharmacol; 2012; (214):279-305. PubMed ID: 23027456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth.
    Ciesielski TH; Marsit CJ; Williams SM
    BMC Pregnancy Childbirth; 2015 Aug; 15():192. PubMed ID: 26303856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progression of major depression during pregnancy and postpartum: a preliminary study.
    Shivakumar G; Johnson NL; McIntire DD; Leveno K
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):571-6. PubMed ID: 23865695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antidepressants and pregnancy: risks and benefits for the mother and child].
    Bérard A; Ramos E
    Med Sci (Paris); 2007 Nov; 23(11):957-60. PubMed ID: 18021707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating mood disorders during pregnancy: safety considerations.
    Eberhard-Gran M; Eskild A; Opjordsmoen S
    Drug Saf; 2005; 28(8):695-706. PubMed ID: 16048355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment resistant depression in women with peripartum depression.
    Cepeda MS; Kern DM; Nicholson S
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):323. PubMed ID: 31477032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study.
    Eid K; Torkildsen ØF; Aarseth J; Flemmen HØ; Holmøy T; Lorentzen ÅR; Myhr KM; Riise T; Simonsen C; Torkildsen CF; Wergeland S; Willumsen JS; Øksendal N; Gilhus NE; Bjørk MH
    Neurology; 2021 Jun; 96(23):e2789-e2800. PubMed ID: 33883236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation.
    Cantarutti A; Merlino L; Monzani E; Giaquinto C; Corrao G
    PLoS One; 2016; 11(12):e0168115. PubMed ID: 27977749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.
    Muzik M; Hamilton SE
    Matern Child Health J; 2016 Nov; 20(11):2268-2279. PubMed ID: 27461022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
    Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J
    Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postpartum bonding: the role of perinatal depression, anxiety and maternal-fetal bonding during pregnancy.
    Dubber S; Reck C; Müller M; Gawlik S
    Arch Womens Ment Health; 2015 Apr; 18(2):187-195. PubMed ID: 25088531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.